Search


Current filters:

Clear current filters  or Add more filters

View Option



Results 1-10 of 48 (Search time: 0.036 seconds).

  Near-absolute expression of the bcl-2 protein identifies a subgroup of stage II breast cancer patients with a most favorable outcome. Results of a clinicopathological study (Journal article)

  Tumor volumetry as predictive and prognostic factor in the management of ovarian cancer (Journal article)

  Immunohistochemical expression of superoxide dismutase (MnSOD) anti-oxidant enzyme in invasive breast carcinoma (Journal article)

  High levels of topoisomerase IIalpha protein expression in diffuse large B-cell lymphoma are associated with high proliferation, germinal center immunophenotype, and response to treatment (Journal article)

  Brain metastases from epithelial ovarian cancer. The Hellenic Cooperative Oncology Group (HeCOG) experience and review of the literature (Journal article)

  ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of malignant glioma (Journal article)

  ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of invasive bladder cancer (Journal article)

  ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of non-small-cell lung cancer (NSCLC) (Journal article)

  ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of pancreatic cancer (Journal article)

  Fluorouracil and leucovorin with or without interferon alfa-2a as adjuvant treatment, in patients with high-risk colon cancer: a randomized phase III study conducted by the Hellenic Cooperative Oncology Group (Journal article)